371 related articles for article (PubMed ID: 20858050)
1. A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis.
Coulet F; Pires F; Rouleau E; Lefol C; Martin S; Colas C; Cohen-Haguenauer O; Giurgea I; Fajac A; Noguès C; Demange L; Hardouin A; Lidereau R; Soubrier F
Genet Test Mol Biomarkers; 2010 Oct; 14(5):677-90. PubMed ID: 20858050
[TBL] [Abstract][Full Text] [Related]
2. Quantitative PCR high-resolution melting (qPCR-HRM) curve analysis, a new approach to simultaneously screen point mutations and large rearrangements: application to MLH1 germline mutations in Lynch syndrome.
Rouleau E; Lefol C; Bourdon V; Coulet F; Noguchi T; Soubrier F; Bièche I; Olschwang S; Sobol H; Lidereau R
Hum Mutat; 2009 Jun; 30(6):867-75. PubMed ID: 19224586
[TBL] [Abstract][Full Text] [Related]
3. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
[TBL] [Abstract][Full Text] [Related]
4. Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers.
Jiménez Ide J; Esteban Cardeñosa E; Palanca Suela S; González EB; Bolufer Gilabert P;
Clin Biochem; 2009 Oct; 42(15):1572-6. PubMed ID: 19616529
[TBL] [Abstract][Full Text] [Related]
5. High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families.
Riahi A; Kharrat M; Lariani I; Chaabouni-Bouhamed H
Fam Cancer; 2014 Dec; 13(4):603-9. PubMed ID: 25069718
[TBL] [Abstract][Full Text] [Related]
6. High-resolution melting analyses for gene scanning of APC, MLH1, MSH2, and MSH6 associated with hereditary colorectal cancer.
Obul J; Itoga S; Abliz M; Sato K; Ishige T; Utsuno E; Matsushita K; Matsubara H; Nomura F
Genet Test Mol Biomarkers; 2012 May; 16(5):406-11. PubMed ID: 22283331
[TBL] [Abstract][Full Text] [Related]
7. High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations.
de Juan I; Esteban E; Palanca S; Barragán E; Bolufer P
Breast Cancer Res Treat; 2009 May; 115(2):405-14. PubMed ID: 18528753
[TBL] [Abstract][Full Text] [Related]
8. Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis.
Takano EA; Mitchell G; Fox SB; Dobrovic A
BMC Cancer; 2008 Feb; 8():59. PubMed ID: 18298804
[TBL] [Abstract][Full Text] [Related]
9. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
Preisler-Adams S; Schönbuchner I; Fiebig B; Welling B; Dworniczak B; Weber BH
Cancer Genet Cytogenet; 2006 Jul; 168(1):44-9. PubMed ID: 16772120
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
Ratajska M; Brozek I; Senkus-Konefka E; Jassem J; Stepnowska M; Palomba G; Pisano M; Casula M; Palmieri G; Borg A; Limon J
Oncol Rep; 2008 Jan; 19(1):263-8. PubMed ID: 18097605
[TBL] [Abstract][Full Text] [Related]
11. Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method.
Hofmann W; Görgens H; John A; Horn D; Hüttner C; Arnold N; Scherneck S; Schackert HK
Hum Mutat; 2003 Jul; 22(1):103-4. PubMed ID: 12815601
[TBL] [Abstract][Full Text] [Related]
12. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
van der Hout AH; van den Ouweland AM; van der Luijt RB; Gille HJ; Bodmer D; Brüggenwirth H; Mulder IM; van der Vlies P; Elfferich P; Huisman MT; ten Berge AM; Kromosoeto J; Jansen RP; van Zon PH; Vriesman T; Arts N; Lange MB; Oosterwijk JC; Meijers-Heijboer H; Ausems MG; Hoogerbrugge N; Verhoef S; Halley DJ; Vos YJ; Hogervorst F; Ligtenberg M; Hofstra RM
Hum Mutat; 2006 Jul; 27(7):654-66. PubMed ID: 16683254
[TBL] [Abstract][Full Text] [Related]
13. Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families.
Gad S; Caux-Moncoutier V; Pagès-Berhouet S; Gauthier-Villars M; Coupier I; Pujol P; Frénay M; Gilbert B; Maugard C; Bignon YJ; Chevrier A; Rossi A; Fricker JP; Nguyen TD; Demange L; Aurias A; Bensimon A; Stoppa-Lyonnet D
Oncogene; 2002 Oct; 21(44):6841-7. PubMed ID: 12360411
[TBL] [Abstract][Full Text] [Related]
14. A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.
Hondow HL; Fox SB; Mitchell G; Scott RJ; Beshay V; Wong SQ; ; Dobrovic A
BMC Cancer; 2011 Jun; 11():265. PubMed ID: 21702907
[TBL] [Abstract][Full Text] [Related]
15. Rapid detection of pathological mutations and deletions of the haemoglobin beta gene (HBB) by High Resolution Melting (HRM) analysis and Gene Ratio Analysis Copy Enumeration PCR (GRACE-PCR).
Turner A; Sasse J; Varadi A
BMC Med Genet; 2016 Oct; 17(1):75. PubMed ID: 27756326
[TBL] [Abstract][Full Text] [Related]
16. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
[TBL] [Abstract][Full Text] [Related]
17. EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients.
Caux-Moncoutier V; Castéra L; Tirapo C; Michaux D; Rémon MA; Laugé A; Rouleau E; De Pauw A; Buecher B; Gauthier-Villars M; Viovy JL; Stoppa-Lyonnet D; Houdayer C
Hum Mutat; 2011 Mar; 32(3):325-34. PubMed ID: 21120943
[TBL] [Abstract][Full Text] [Related]
18. An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition.
Muller D; Rouleau E; Schultz I; Caputo S; Lefol C; Bièche I; Caron O; Noguès C; Limacher JM; Demange L; Lidereau R; Fricker JP; Abecassis J
BMC Med Genet; 2011 Sep; 12():121. PubMed ID: 21939546
[TBL] [Abstract][Full Text] [Related]
19. Validation of a quantitative PCR-high-resolution melting protocol for simultaneous screening of COL1A1 and COL1A2 point mutations and large rearrangements: application for diagnosis of osteogenesis imperfecta.
Gentile FV; Zuntini M; Parra A; Battistelli L; Pandolfi M; Pals G; Sangiorgi L
Hum Mutat; 2012 Dec; 33(12):1697-707. PubMed ID: 22753364
[TBL] [Abstract][Full Text] [Related]
20. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
Hernan I; Borràs E; de Sousa Dias M; Gamundi MJ; Mañé B; Llort G; Agúndez JA; Blanca M; Carballo M
J Mol Diagn; 2012; 14(3):286-93. PubMed ID: 22426013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
